Charles River Laboratories International, Inc. (CRL) Insider Trading Activity

NYSE$332.06-19.81 (-5.63%)
Market Cap
$16.95B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
364 of 849
Rank in Industry
13 of 38

CRL Insider Trading Activity

CRL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$7,338
2
13
Sells
$52,066,240
13
87

Related Transactions

LaPlume Joseph WEVP, Corp Strategy & Develop
1
$4,364
0
$0
$4,364
Coleman GlennEVP & Chief Financial Officer
1
$2,974
0
$0
$2,974
Andrews Nancy Cdirector
0
$0
1
$163,443
$-163,443
Creamer Victoria LEVP & Chief People Officer
0
$0
1
$1.08M
$-1.08M
Knell Michael GunnarSVP, Finance and CAO
0
$0
1
$1.73M
$-1.73M
Girshick BirgitChief Executive Officer
0
$0
1
$1.82M
$-1.82M
Parisotto Shannon MCEVP, Disc & Safety Assessment
0
$0
5
$4.01M
$-4.01M
FOSTER JAMES Cdirector
0
$0
4
$43.26M
$-43.26M

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery …

Insider Activity of Charles River Laboratories International, Inc.

Over the last 12 months, insiders at Charles River Laboratories International, Inc. have bought $7,338 and sold $52.07M worth of Charles River Laboratories International, Inc. stock.

On average, over the past 5 years, insiders at Charles River Laboratories International, Inc. have bought $855,344 and sold $20.63M worth of stock each year.

Highest buying activity among insiders over the last 12 months: LaPlume Joseph W (EVP, Corp Strategy & Develop) — $4,364. Coleman Glenn (EVP & Chief Financial Officer) — $2,974.

The last purchase of 10 shares for transaction amount of $2,974 was made by Coleman Glenn (EVP & Chief Financial Officer) on 2026‑09‑30.

List of Insider Buy and Sell Transactions, Charles River Laboratories International, Inc.

2026-10-22SaleFOSTER JAMES Cdirector
24,042
0.0511%
$350.00
$8.41M
+5.42%
2026-10-21SaleParisotto Shannon MCEVP, Disc & Safety Assessment
2,156
0.0045%
$344.41
$742,548
+3.60%
2026-10-05SaleParisotto Shannon MCEVP, Disc & Safety Assessment
981
0.002%
$308.44
$302,580
+1.51%
2026-09-30PurchaseColeman GlennEVP & Chief Financial Officer
10
<0.0001%
$297.43
$2,974
+4.57%
2026-08-25SaleFOSTER JAMES Cdirector
33,561
0.0702%
$300.00
$10.07M
-0.85%
2026-08-19SaleParisotto Shannon MCEVP, Disc & Safety Assessment
2,039
0.0043%
$294.12
$599,711
+1.79%
2026-08-18SaleAndrews Nancy Cdirector
573
0.0012%
$285.24
$163,443
+5.71%
2026-08-11SaleGirshick BirgitChief Executive Officer
6,500
0.0134%
$279.90
$1.82M
+4.46%
2026-08-11SaleParisotto Shannon MCEVP, Disc & Safety Assessment
3,714
0.0076%
$279.66
$1.04M
+4.46%
2026-08-10SaleFOSTER JAMES Cdirector
28,733
0.0588%
$275.00
$7.9M
+6.32%
2026-08-06SaleCreamer Victoria LEVP & Chief People Officer
4,179
0.0084%
$259.16
$1.08M
+10.69%
2026-08-06SaleKnell Michael GunnarSVP, Finance and CAO
6,645
0.0134%
$260.38
$1.73M
+10.69%
2026-08-05SaleParisotto Shannon MCEVP, Disc & Safety Assessment
5,046
0.0106%
$263.00
$1.33M
+12.52%
2026-06-29SaleFOSTER JAMES Cdirector
75,000
0.1553%
$225.00
$16.88M
+25.17%
2026-03-03PurchaseLaPlume Joseph WEVP, Corp Strategy & Develop
25
<0.0001%
$174.54
$4,364
+27.68%
2025-08-22SaleLaPlume Joseph WEVP, Corp Strategy & Develop
400
0.0008%
$163.72
$65,488
+10.88%
2025-08-18SaleLaPlume Joseph WEVP, Corp Strategy & Develop
800
0.0016%
$157.60
$126,080
+13.94%
2025-08-07SaleLaPlume Joseph WEVP, Corp Strategy & Develop
400
0.0008%
$150.04
$60,016
+18.74%
2025-05-15SaleMASSARO GEORGEdirector
140
0.0003%
$137.57
$19,260
+20.90%
2025-05-14SaleMASSARO GEORGEdirector
140
0.0003%
$140.74
$19,703
+20.85%
Total: 552
*Gray background shows transactions not older than one year

Insider Historical Profitability

6.72%
Girshick BirgitChief Executive Officer
36013
0.0748%
$12.67M214
+6.76%
FOSTER JAMES Cdirector
31596
0.0656%
$11.12M788
+5.98%
Coleman GlennEVP & Chief Financial Officer
27762
0.0576%
$9.77M10
LaPlume Joseph WEVP, Corp Strategy & Develop
27448
0.057%
$9.66M125
GILLETT NANCYCorporate Executive VP
11034
0.0229%
$3.88M141
+0.49%
Ho John CSenior Vice President
8950
0.0186%
$3.15M10
+15.04%
WALLMAN RICHARD Fdirector
0
0%
$0413
+7.48%
*Gray background shows insiders who have made transactions during last year

CRL Institutional Investors: Active Positions

Increased Positions295+43.9%10M+19.93%
Decreased Positions295-43.9%8M-15.75%
New Positions113New2MNew
Sold Out Positions85Sold Out1MSold Out
Total Postitions6720%53M+4.18%

CRL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1.18M11.92%5.84M+27,989+0.48%2025-09-30
Blackrock, Inc.$780,545.007.87%3.86M+199,934+5.47%2025-09-30
Wellington Management Group Llp$645,814.006.51%3.19M-577,338-15.32%2025-09-30
Allspring Global Investments Holdings, Llc$440,859.004.45%2.18M-113,185-4.94%2025-09-30
State Street Corp$370,662.003.74%1.83M-27,634-1.49%2025-09-30
Ariel Investments, Llc$301,626.003.04%1.49M+74,750+5.28%2025-09-30
Harris Associates L P$298,182.003.01%1.47M+310,149+26.67%2025-09-30
Geode Capital Management, Llc$256,415.002.59%1.27M+34,516+2.8%2025-09-30
Invesco Ltd.$252,859.002.55%1.25M+12,035+0.97%2025-09-30
Bank Of America Corp /De/$235,485.002.37%1.16M+137,335+13.38%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.